About Rui Laboratories
Rui Laboratories is a company based in Visakhapatnam (India) founded in 2017. It operates as a B2B. The company has 117 employees as of March 31, 2023. Rui Laboratories offers products and services including Active Pharmaceutical Ingredients and Pharmaceutical Intermediates. Rui Laboratories operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Visakhapatnam, India
- Employees 117 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Rui Laboratories Private Limited
- Date of Incorporation 16 Nov, 2017
- Jurisdiction Rambilli Mandal, Andhra Pradesh, India
-
Annual Revenue
$5.13 M (USD)36.04as on Mar 31, 2023
-
Net Profit
-$431.69 K (USD)50.47as on Mar 31, 2023
-
EBITDA
$529.32 K (USD)196.22as on Mar 31, 2023
-
Latest Funding Round
-
Investors
-
Employee Count
117
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rui Laboratories
Rui Laboratories offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and Pharmaceutical Intermediates.
Key ingredients in medicines that deliver therapeutic effects.
Compounds used in the synthesis of active pharmaceutical ingredients.
Funding Insights of Rui Laboratories
Investments & Acquisitions by Rui Laboratories
Financial Statements - Rui Laboratories
Rui Laboratories Comparisons
Competitors of Rui Laboratories
Rui Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical and biotechnology company
|
|
| domain | founded_year | HQ Location |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| domain | founded_year | HQ Location |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
APIs are developed and manufactured for therapeutic areas.
|
|
| domain | founded_year | HQ Location |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Latest news on Rui Laboratories
Frequently Asked Questions about Rui Laboratories
Rui Laboratories was founded in 2017.
Rui Laboratories is headquartered in Visakhapatnam, India. It is registered at Visakhapatnam, Andhra Pradesh, India.
As of Mar 31, 2023, the latest employee count at Rui Laboratories is 117.
Annual revenue of Rui Laboratories is $5.13M as on Mar 31, 2023.
Rui Laboratories, established in 2017, specializes in manufacturing pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Operating as a medium-scale industry in India, with facilities in Visakhapatnam and Hyderabad, they prioritize quality production that meets national and international standards. They emphasize safe environments, timely delivery, and ethical practices to serve global customers in the pharmaceutical sector.
Rui Laboratories's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Rui Laboratories offers Active Pharmaceutical Ingredients and Pharmaceutical Intermediates.